ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline FGI Q1 2026 Earnings Earnings Beat Expectations Despite Stock Decline VRCA Q1 2026 Earnings EPS Misses Estimates as Commercialization Costs Weigh on Results CELC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress but Stock Slips MBC Q1 2026 Earnings Profit Beat Defies Expectations Amid Cost Discipline SCVL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Retail Environment